The N-terminal domains target TNF receptor-associated factor-2 to the nucleus and display transcriptional regulatory activity

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 319-324

  Min, Wang ^a,d   Bradley, John R ^b   Galbraith, Jennifer J ^b   Jones, Sally J ^b   Ledgerwood, Elizabeth C ^b,c   Pober, Jordan S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Genemedicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN TARGETING; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BIOLOGICAL TRANSPORT; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; PEPTIDE FRAGMENTS; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION, GENETIC; TRANSFECTION; UMBILICAL VEINS;

EID: 0031858994     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rothe, M., S. C. Wong, W. J. Henzel, and D. V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75kDa tumor necrosis factor receptor. Cell 78:681.
2. Hu, H. M., K. O'Rourke, M. S. Boguski, and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069.
3. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF-2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
4. Cheng, G., A. M. Cleary, Z. S. Ye, D. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF-1, a relative of TRAF, in CD40 signaling. Science 267:1494.
5. Gedrich, R. W., M. C. Gilfillan, C. S. Duchett, J. L. Van Dongen, and C. B. Thompson. 1996. CD30 contains two binding sites with different receptor specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271:12852.
6. Lee, S. Y., S. L. Lee, G. Kandala, M. L. Liou, H. C. Liou, and Y. Choi. 1996. CD3D-TRAF interaction: NF-κB activation and binding specificity. Proc. Natl. Acad. Sci. USA 93:9699.
7. Ishida, T., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J. I. Imue. 1996. TRAF5, a novel tumor necrosis factor receptor-associated family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93:9437.
8. Nakano, H., H. Oshima, W. Chung, L. C. F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:14661.
9. Cao, Z., J. Xiong, M. Taheuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443.
10. Mackay, F., H. Loetscher, D. Stueber, G. Gehr, and W. Lesslauer. 1993. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177:1277.
11. Slowik, M. R., L. G. DeLuca, W. Fiers, and J. S. Pober. 1993. Tumor necrosis factor (TNF) activates human endothelial cells through the p55 TNF receptor but the p75 receptor contributes to activation at low TNF concentration. Am. J. Pathol. 134:1724.
12. Karmann, K., C. C. W. Hughes, J. Schechner, W. C. Fanslow, and J. S. Pober. 1995. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92:4342.
13. Karmann, K., W. Min, W. C. Fanslow, and J. S. Pober. 1996. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J. Exp. Med. 184:173.
14. Hsu, H., H. B. Shu, M. G. Pan, and D. V. Goeddel. 1996. TRADD-TRAF-2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299.
15. Wang Min, and J. S. Pober. 1997. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-κB and TRAF-RAC/CDC42-JNK-cJun/ATF-2 pathways. J. Immunol. 159:3508.
16. Lee, S. Y., A. Reichlin, A. Santana, K. A. Sokol, M. C. Nussenzweig, and Y. Choi. 1997. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7:703.
17. Yeh, W.-C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, P. Ohashi, M. Rothe, D. V. Goeddel, and W. W. Mak. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715.
18. Malinin, N. L., M. P. Boldin, A. V. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 395:54.
19. Régnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of a IκB kinase. Cell 90:373.
20. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB: a mechanism for NF-κB activation. Mol Cell. Biol. 13:3301.
21. Liu, Z. G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-[kappa]B activation prevents cell death. Cell 87:565.
22. Takahashi, K., Y. Sawasaki, J. I. Hata, K. Mukai, and T. Goto. 1990. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell. Dev. Biol. 25:265.
23. Takeuchi, M., M. Rothe, and D. V. Goeddel. 1996. Anatomy of TRAF2. J. Biol. Chem. 271:19935.
24. Bradley, J. R., S. Thiru, and J. S. Pober. 1994. Disparate localization of 55kd and 75kd TNF receptors in human endothelial cells. Am. J. Pathol. 146:27.
25. Sierra-Honigmann, M. R., J. R. Bradley, and J. S. Pober. 1996. "Cytosolic" phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab. Invest. 74:684.
26. Hicks, G. R., and N. Raukhel. 1995. Protein imports into the nucleus: an integrated view. Annu. Rev. Cell. Dev. Biol. 11:155.
27. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, K. Yamamoto, and O. Silvennoinen. 1995. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13:369.
28. Gumbiner, B. M. 1995. Signal transduction of beta-catenin. Curr. Opin. Cell Biol. 7:534.
29. Behrens, J., J. P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmaier. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638.